期刊文献+

胰腺癌中14-3-3蛋白各亚型的表达及其临床意义

Expressions of 14-3-3 protein isoforms and their significance in pancreatic ductal adenocarcinoma
下载PDF
导出
摘要 目的探讨14-3-3蛋白各亚型在人胰腺导管腺癌组织中的表达情况及其临床意义。方法采用石蜡包埋组织进行免疫组化染色,分析14-3-3蛋白各亚型在30例胰腺癌和19例胰腺癌旁正常组织中的表达状态,探讨其与胰腺癌临床病理参数之间的关系。结果 14-3-3蛋白β、γ、ε、ζ、η、θ和σ7个亚型在胰腺癌组织原发灶中表达阳性率分别为70%(21/30)、83.33%(25/30)、26.67%(8/30)、73.33%(22/30)、33.33%(10/30)、30%(9/30)和43.33%(13/30)。其中癌旁正常胰腺组织的β、γ、ζ、η和σ亚型阳性率与胰腺癌组织比较差异显著(P<0.05),ε和θ亚型阳性率比较差异不显著(P>0.05);14-3-3蛋白阳性表达率与胰腺癌的分化程度、恶性级别及淋巴结转移均无明显关系(P>0.05)。结论 14-3-3蛋白7个亚型中有5个在胰腺癌组织中高表达,表明该蛋白在胰腺癌的发生过程中具有重要作用,并且有可能成为胰腺癌基因治疗新的靶点。 Objective To investigate the expression of 14-3-3 proteins and their clinical significance in pancreatic ductal adenocarcinoma. Methods Seven 14-3-3 protein isoforms (β、γ、ε、ζ、η、θ and σ) were examined in 30 pancreatic cancer tissues and 19 adjacent normal pancreatic tissues by immunohistochemieal EnVision method. Results The positive rate of protein 14-3-3 β、γ、ε、ζ、η、θ and σ isoforms in pancreatic cancer tissues was 70. 00% ( 21/30 ), 83.33% (25/30), 26. 67(8/30), 73.33% (22/30), 33.33 (10/30), 30. 00 (9/30) and 43.33(13/30), and those in adjacent normal pancreatic tissues was 5.26% ( 1/19 ) , 15.79% (3/19) , 42. 11% (8/19) , 5. 26% (1/19) , 5. 26% % (1/19), 21.05% (4/19) and 5.26% (1/19), respectively. A significant difference was found between the two groups in the expression of β、γ、ζ、η and σ isoforms. But no relationship was found between 14-3-3 proteins overexpression and differentiation, malignant degree, or lymph node metastasis. Conclusions The expression of 14-3-3 β、γ、ζ、η and σ protein is higher in pancreatic cancer than adjacent normal pancreatic tissues. They may play an important role in the tumorigenesis of pancreatic ductal adenocareinoma.
出处 《诊断病理学杂志》 CSCD 2010年第4期294-297,共4页 Chinese Journal of Diagnostic Pathology
关键词 胰腺 导管腺癌 14—3-3蛋白 免疫组化 Pancreatic Adenoeareinoma 14-3-3 protein Immunohistochemistry
  • 相关文献

参考文献17

  • 1Jemal A, Siegel R, Ward E, et al. Cancer statistics 2009 [ J]. CA Cancer J Clin, 2009,59(4) :225 -249.
  • 2Yang HY, Wen YY, Chen CH, et al. 14-3-3 sigma positively regulates p53 and suppresses tumor growth[J]. Mol Cell Biol, 2003,23(20) :7096 -7107.
  • 3Friedrich M, Villena-Heinsen C, Reitnauer K, et al. Malignancies of the uterine corpus and immunoreactivity score of the DNA "mismatch-repair" enzyme human Mut-S-homologon-2 [ J ]. J Histochem Cytochem, 1999,47 ( 1 ) : 113 - 118.
  • 4Moore BW, Mcgregor D. Chromatographic and electrophoretic fractionation of soluble proteins of brain and liver [J]. J Biol Chem, 1965,240 : 1647 - 1653.
  • 5Tzivion G, Gupta VS, Kaplun L, et al. 14-3-3 proteins as potential oneogenes[J]. Semin Cancer Biol, 2006, 16(3) : 203 -213.
  • 6Guweidhi A, Kleeff J, Giese N, et al. Enhanced expression of 14-3-3sigma in pancreatic cancer and its role in cell cycle regulation and apoptosis[ J]. Carcinogenesis, 2004,25(9) :1575 - 1585.
  • 7Rhodes DR, Yu J, Shanker K, et al. Oncomine: a cancer microarray database and integrated data-mining platform [J]. Neoplasia, 2004,6( 1 ) :1 -6.
  • 8Nomura M, Shimizu S, Sugiyama T, et al. 14-3-3 interacts directly with and negatively regulates pro-apoptotic Bax [J].J Biol Chem, 2003,278 (3) :2058 - 2065.
  • 9Margolis SS, Kornbluth S. When the checkpoints have gone: insights into Cdc25 functional activation [ J ]. Cell Cycle, 2004,3 (4) :425 -428.
  • 10Gasco M, Sullivan A, Repellin C, et al. Coincident inactivation of 14-3-3 sigma and p16INK4a is an early event in vulval squamous neoplasia [J]. Oncogene, 2002,21 ( 12 ) : 1876 - 1881.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部